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Gene expression profiling identifies different
sub-types of retinoblastoma
G Kapatai1,5, M-A Brundler1,2, H Jenkinson3, P Kearns1,3, M Parulekar4, A C Peet1,3 and C M McConville*,1
1School of Cancer Sciences, Vincent Drive, University of Birmingham, Birmingham B15 2TT, UK; 2Department of Histopathology,
Birmingham Children’s Hospital, Birmingham B4 6NH, UK; 3Department of Oncology, Birmingham Children’s Hospital,
Birmingham B4 6NH, UK and 4Department of Ophthalmology, Birmingham Children’s Hospital, Birmingham B4 6NH, UK
Background: Mutation of the RB1 gene is necessary but not sufficient for the development of retinoblastoma. The nature of
events occurring subsequent to RB1 mutation is unclear, as is the retinal cell-of-origin of this tumour.
Methods: Gene expression profiling of 21 retinoblastomas was carried out to identify genetic events that contribute to
tumorigenesis and to obtain information about tumour histogenesis.
Results: Expression analysis showed a clear separation of retinoblastomas into two groups. Group 1 retinoblastomas express
genes associated with a range of different retinal cell types, suggesting derivation from a retinal progenitor cell type. Recurrent
chromosomal alterations typical of retinoblastoma, for example, chromosome 1q and 6p gain and 16q loss were also a feature of
this group, and clinically they were characterised by an invasive pattern of tumour growth. In contrast, group 2 retinoblastomas
were found to retain many characteristics of cone photoreceptor cells and appear to exploit the high metabolic capacity of this
cell type in order to promote tumour proliferation.
Conclusion: Retinoblastoma is a heterogeneous tumour with variable biology and clinical characteristics.
Disruption of the RB pathway as a consequence of RB1 gene
mutation or mutation of other pathway components (e.g., D-type
cyclins, CDK4 or p16INK4A) is common to most if not all human
cancers. Although these mutations are assumed to impact primarily
on cell cycle regulation, RB1 has many additional roles, including
regulation of chromosome stability, senescence and cellular
differentiation (Indovina et al, 2013). Regulation of permanent cell
cycle withdrawal and terminal differentiation are especially relevant
in a developmental context and may be important in the prototype
RB1-associated tumour, retinoblastoma. An understanding of the
molecular pathogenesis of retinoblastoma may also shed light on
additional roles of pRB in other tumour types which also show high
frequencies of RB1 gene mutation/deletion (rather than cyclin/CDK/
CDKI mutations), for example, osteosarcoma, small-cell lung cancer,
bladder cancer and hepatocellular carcinoma.
Knowledge of the cell-of-origin of retinoblastoma is important to
understand the role of RB1 mutation in this tumour. The
mammalian retina is composed of six neuronal cell types, rod,
cone, horizontal, amacrine, bipolar and ganglion cells, and one glial
cell type, Mu¨ller glia (Figure 1), all of which are derived from a
common retinal progenitor cell (RPC) and arise in an evolutionarily
conserved birth order during development. Retinal progenitor cells
at a specific stage of development show competence to produce post-
mitotic precursor cells, with the potential for terminal differentiation
into a limited subset of retinal cell types, for example, early
progenitor cells give rise to ganglion and cone precusor cells, while
late progenitor cells give rise to Mu¨ller glial and bipolar precursor
cells (Livesey and Cepko, 2001; Dyer and Bremner, 2005).
Several studies of both human retinoblastoma and mouse
retinoblastoma models have sought to define the retinal cell-of-
origin of retinoblastoma and to understand why these cells are so
susceptible to oncogenic transformation following RB1 mutation.
These studies have reached a variety of conclusions, suggesting that
retinoblastomas may be heterogeneous in their origin. A detailed
immunohistochemical and genetic examination of human retino-
blastoma led Xu et al (2009) to suggest, for example, that human
retinoblastoma has properties of a cone precursor cell. Investiga-
tion of mouse models of retinoblastoma have generally implicated
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other cell types, however, including horizontal, amacrine and
Mu¨ller glial precursors (Chen et al, 2004; Ajioka et al, 2007; Pajovic
et al, 2011). A further study concluded that multiple cell type-
specific developmental programs, including those of amacrine,
horizontal, photoreceptor and progenitor cells, are co-expressed in
individual human retinoblastoma cells (McEvoy et al, 2011).
A general finding from studies of both human and murine
retinoblastoma is that secondary mutations in addition to loss of
RB1 are required for tumour development. It has been reported,
for example, that loss of RB1 in humans induced non-proliferative
retinoma and that increasing genome instability was correlated
with progression to retinoblastoma (Dimaras et al, 2008). The
observation of recurrent chromosomal alterations including 1q and
6p gain and 16q loss in up to 50% of all retinoblastomas suggests
that genes on these chromosomes may contribute to tumour
development and progression. A number of genes of interest have
been highlighted, for example, MDM4 and KIF14 on 1q, E2F3 on
6p, CDH11 and RBL2/p130 on 16q (Corson and Gallie, 2007).
However, the significance of many additional genes that show
altered patterns of expression in association with these chromo-
somal alterations (e.g., CENPF, DEK, KIFC1) remains to be
determined (Corson and Gallie, 2007).
In this study, we have used gene expression profiling to gain further
insight into the molecular pathways which drive retinoblastoma
tumorigenesis and their relationship to retinal developmental processes.
MATERIALS AND METHODS
Patient samples. Frozen tissue from 21 retinoblastomas,
enucleated without prior treatment, was used for microarray
analyses and qRT-PCR. Tissue was obtained from dissected globes
and was divided for RNA and DNA extraction. Histopathology was
assessed (blinded to genetic data) on tumour tissue, which was
formalin-fixed and paraffin-embedded at the time of diagnosis.
Five to 10 tissue sections were assessed according to the guidelines
of the International Retinoblastoma Staging Working Group
(Sastre et al, 2009). Patients were all treated at the Birmingham’s
Children Hospital, UK, and consent was obtained for tissue
banking for ethically approved research. The study was approved
by the local Research Ethics Committee.
Array-CGH. DNA was prepared from retinoblastomas and
peripheral blood lymphocytes from 10 normal healthy individuals
using phenol/chloroform extraction (normal DNAs were then
pooled for further processing). DNA was sonicated (100–1000 bp),
purified (Qiagen Ltd, Crawley, UK) and then amplified in a
two part procedure using primer A (50-GTTTCCCAGTC
ACGGTCNNNNNNNNN-30) for initial linear amplification,
followed by primer B (50-GTTTCCCAGTCACGGTC-30) (Wang
et al, 2003) for 30 cycles of amplification with the inclusion of
aminoallyl-dUTP to faciliate post amplification labelling. Frag-
mentation and labelling of 7.5 mg of amplified DNA was performed
using the GeneChip WT dsDNA Terminal Labeling kit (Affyme-
trix UK Ltd, High Wycombe, UK). Hybridization to Affymetrix
GeneChip Human Promoter 1.0R tiling arrays was carried out
according to the standard Affymetrix procedures.
Gene expression arrays. Total RNA was isolated from retino-
blastoma samples using Trizol extraction (Life Technologies Ltd,
Paisley, UK), and additional purification was carried out using the
Qiagen RNeasy system (Qiagen). RNA integrity was assessed using
the Agilent Bioanalyzer 2100 (Agilent Technologies UK Ltd,
Wokingham, UK). First- and second-strand cDNA synthesis,
labelling and hybridisation to Affymetrix Human Gene 1.0ST
arrays were performed according to the standard Affymetrix
protocol. Affymetrix data were extracted, normalised and sum-
marised using the robust multi-average method implemented in
the Affymetrix Expression Console. CEL files from the same
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Figure 1. The human retina. (A) Organisation of the retina. (B) A H&E-stained section of the retina shows the outer and inner segments (OS, IS) of
rod and cone photoreceptor cells. Photoreceptor nuclei form the outer nuclear layer (ONL). Nuclei of bipolar, amacrine, horizontal and Mu¨ller glial
cells form the inner nuclear layer (INL), and the nuclei of ganglion cells form the ganglion cell layer (GCL). The outer plexiform layer (OPL) contains
the processes and synaptic terminals of photoreceptors, horizontal and bipolar cells. The inner plexiform layer (IPL) contains the processes and
synaptic terminals of bipolar, amacrine and ganglion cells. The processes of Mu¨ller glial cells fill all the retinal space not occupied by neurons and
blood vessels. (Reproduced from Sung and Chuang (2010)). Abbreviations: A, amacrine cell; B, bipolar cell; C, cone; G, ganglion cell; H, horizontal
cell; M, Mu¨ller glial cell; R, rod; RPE, retinal pigment epithelium.
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Affymetrix array platform (Human Gene 1.0ST) were downloaded
from the GEO database (http://www.ncbi.nlm.nih.gov/geo/) for
normal adult retina (GSM607947, GSM607948) and 96-day human
fetal retina (GSM460264), and were normalised and summarised in
parallel with retinoblastoma samples.
Array data analysis. CEL files from Affymetrix GeneChip Human
Promoter 1.0R Tiling Arrays were analysed for copy number
alterations using Partek Genomic Suite (PGS). Data were first log2
transformed and quantile normalised (with adjustment for GC
content and probe sequence). Using the normal sample as baseline,
copy number estimates were then obtained for each of 4.2 million
probes on the array and segmentation applied with parameters set
at: minimum number of genomic markers: 10, P-value threshold:
0.01 and signal to noise: 1.0.
Principal component and hierarchical clustering (HC) analysis
of expression data from Affymetrix Human Gene 1.0ST arrays was
carried out using PGS. Default parameters were used for principal
component analysis (PCA; dispersion matrix: correlation; eigen-
vector scaling: normalised) and elipsoids were plotted at 2 standard
deviations from the centroid of each group. Hierarchical clustering
metrics used were Pearson correlation (distance measurement) and
average linkage clustering. For other analyses, summarised
Affymetrix data were imported into MultiExperiment Viewer
(Saeed et al, 2006). Differentially expressed genes were identified
using SAM (Significance Analysis of Microarrays) with a q-value or
false discovery cutoff at 5%. Functional annotation of lists of
differentially expressed genes was carried out using the Database
for Annotation, Visualisation and Integrated Discovery (DAVID)
(Huang et al, 2009). Annotation categories searched included
GOTERM_BP (Biological Process), GOTERM_MF (Molecular
Function) and pathways from the Biocarta, Kegg and Reactome
databases. Hierarchical clustering of the reduced data set (retinal-
associated genes) was performed using the GenePattern Software
Suite (Reich et al, 2006). Geneset enrichment analysis (GSEA) was
carried out using canonical pathways included in the Molecular
Signatures Database (v3.0) of the GSEA software package
(Subramanian et al, 2005). Data for GSEA was preprocessed so
that only a single probeset for each gene (that with the highest
expression) was included.
Table 1. Characteristics of retinoblastomas
Chromosome
copy number
alterationsf
RB
ID
Histological
differentiation
Types of
rosettes
Extent of
rosettesa
Apoptosisb
Choroid
invasionc
Choroid
invasion
depth
Optic nerve
invasiond
Scleral
invasion
Genetic
groupe
1q
gain
6p
gain
16q
loss
RB1 Poor FW, N 1 2 2 D 3 0 1 þ  þ
RB3 Poor N 1 2 0 S 1 0 1 þ þ 
RB4 Poor N 2 2 1 D 3 0 1  þ þ
RB6 Well FW 3 2 0 S 0 0 1  (þ )g 
RB7 Poor  0 2 2 D 3 0 1 þ  þ
RB9 Poor  0 2 2 D 4 0 1   
RB10 Well FW, N 4 2 0 S 0 0 1  þ 
RB11 Poor FW, P 1 2 0 S 2 0 1  þ 
RB16 Intermed FW, N, P 2 2 2 D 3 0 1 ND ND ND
RB17 Poor N 1 2 1 D 3 0 1   
RB18 Poor P 0 2 2 D 1 0 1 þ þ þ
RB19 Poor FW, N, P 1 2 2 D 1 0 1  þ 
RB20 Well FW 3 2 0 S 0 0 1  þ 
RB2 Well FW 4 1 1 D 3 0 2   
RB5 Well FW, N 3 1 0 S 0 0 2   
RB8 Well FW 3 1 2 D 1 1 2   
RB14 Well FW, N 4 1 0 S 0 0 2 ND ND ND
RB15 Intermed FW 2 2 0 S 0 0 2   
RB21 poor FW, N, P 1 2 0 S 0 0 2   
RB12 Well FW, N 3 1 1 D 2 0 3   
RB13 Well FW, N 4 1 0 S 0 0 3   
Abbreviations: FW¼Flexner-Wintersteiner (characteristic of retinoblastoma); N¼Homer-Wright rosettes (associated with tumours of neural origin); ND¼ not determined; P¼pallisading;
S, D¼ superficial, deep choroidal invasion.
aExtent of rosettes: 0, none; 1, o10%; 2, 10–25%; 3, 25–50%; 4, 450%.
bApoptosis: 1, low (patchy distribution); 2, high (observed over whole tumour area).
cChoroid invasion: 0, none; 1, localised; 2, extensive.
dOptic nerve invasion: 0, none; 1, pre-laminar; 2, intra-laminar; 3, retro-laminar; 4, to resection margin.
eGenetic group–see text.
fþ / : Presence/absence of chromosome copy number alteration; nd: not done.
gGain restricted to B3Mb within 6p21.3.
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Chromosome 1q, 6p and 16q differentially expressed genes (fold
change X1.5, qp0.05) were defined as potentially cancer related
on the basis of encoding proteins of known function and citations
in the literature, implicating involvement in cancer or in cellular
regulatory processes.
Real-time RT-PCR. One microgram of total RNA was used for
cDNA synthesis using the QuantiTect Reverse Transcription kit
(Qiagen) according to the manufacturer’s protocol. Quantitative
RT-PCR was performed in 1 SYBR Green PCR mixture
(Applied Biosystems, Warrington, UK), 1 ml diluted cDNA (1 : 5)
and 0.5 mM gene-specific primers (Supplementary Table S7)
designed using Primer 3 (http://frodo.wi.mit.edu) software. The
reactions were performed in triplicate and b-actin was used as
endogenous normalisation control.
RESULTS
Retinoblastoma is a heterogeneous tumour. Initial exploratory
analysis of the gene expression profiles of 21 retinoblastomas
(Table 1) was carried out to assess heterogeneity. Principal component
analysis showed a clear separation between normal retina and
retinoblastoma, and in addition indicated a further sub-division of
retinoblastomas into two main groups with 13 and 6 members,
respectively (Figure 2A). A further two samples (group 3) were
subsequently shown to be more similar to normal retina (see below).
This grouping was also shown in a HC analysis (Figure 2B).
Functional annotation of differentially expressed genes in retina
and retinoblastma (fold change X2.0, qp0.05; Supplementary
Table S1) indicated that, overall, the most highly enriched gene
ontology (GO) categories were those associated with photoreceptor
differentiation/maintenance and phototransduction in normal
adult retina, and with cell cycle and mitosis in retinoblastoma
(Table 2). More detailed examination of the differences between
the three groups, using pairwise comparisons (Supplementary
Tables S2–S4), identified significant enrichment of GO categories
relating to mitosis, spindle function, DNA replication and
cytokinesis in groups 1 and 2 relative to group 3 (Table 3). Group
2 was additionally characterised by GO categories relating to
photoreceptor development and differentiation, while in both
groups 2 and 3 phototransduction was also highlighted (Table 4).
The conclusion drawn from these results is that groups 1 and 2
appear to have the greatest proliferative potential, but these groups
differ in the extent of photoreceptor differentiation. The expression
profile of group 2 retinoblastomas appears to be most consistent
with derivation from a retinal cone photoreceptor lineage. Group 1
retinoblastomas may derive either from a different retinal lineage
or from an early uncommitted cell type, for example, a RPC.
Retinoblastomas show different patterns of retinal gene
expression. To investigate the histogenesis of retinoblastoma
groups in more detail, data were extracted for all genes on the
array associated with retinal development and function. Genes
were identified using the Affymetrix gene description; also
included were genes listed by Hennig et al (2008), which function
in the regulation of photoreceptor gene expression and genes listed
by Byerly and Blackshaw (2009) with roles in vertebrate retinal
development. Unsupervised HC of tumours, based on 80 retina-
associated genes, produced an identical grouping to that obtained
with PCA and with HC of the complete data set (Figure 3), and
provided information about the expression of genes associated with
different retinal cell types in each of the tumour groups.
The expression of cone photoreceptor-enriched transcription
factors, RXRG and THRB, was of particular interest in view of the
reported cone precursor origin of retinoblastoma (Xu et al, 2009).
The expression of RXRG and THRB was increased 1.4- and
1.5-fold, respectively, in group 2 retinoblastomas relative to group
1, and was three- to five-fold increased relative to normal adult
retina. Furthermore, the high expression in group 2 of downstream
genes encoding cone opsins (OPN1MW, OPN1LW), cone arrestin
(ARR3) and cone phosphodiesterases (PDE6C, PDE6H) is
consistent with the development of group 2 retinoblastomas from
a cone lineage cell. The fact that there was little or no expression of
either rod rhodopsin (RHO) or rod arrestin (SAG) in this group
confirms that the observed gene expression profile is not a
consequence of the inclusion of normal retinal tissue. Expression of
RHO and SAG were 170- and 50-fold higher, respectively, in
normal retina, where rods outnumber cones by B20 : 1. In
contrast, the two group 3 samples (RB12 and RB13) showed
high-level expression of both cone and rod genes (e.g., OPN1MW/LW,
RHO, NR2E3), as well as several genes characteristic of other retinal
neuronal and glial cell types (HES1, PAX6, PROX1, VSX2, RLBP1/
CRALBP) (Livesey and Cepko, 2001; Cid et al, 2010; Joly et al, 2011).
Their similarity to the normal retinal samples (Figure 3) is suggestive
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Figure 2. Retina and retinoblastoma gene expression data. (A) Principal component analysis shows separation of retinoblastoma samples into
three groups, group 1 (blue symbols), group 2 (red symbols) and group 3 (green symbols). Normal adult retina and fetal retina are from http://
www.ncbi.nlm.nih.gov/geo/. (B) Hierarchical clustering (HC) of the same samples. Colour coding shows concordance with PCA.
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of inclusion of some normal retinal tissue, and these two samples were
not analysed further.
Although the expression of RXRG and THRB was moderately
reduced rather than absent in group 1, a much greater decrease
(six- to eight-fold) in the expression of OPN1MW/LW genes
relative to group 2 suggests that group 1 retinoblastomas do not
complete the cone differentiation programme and may be arrested
at an earlier stage of development. It was noted that some group 1
retinoblastomas also showed variable upregulation (p1.5-fold) of a
number of genes encoding transcription factors implicated more
generally in eye and retinal development, particularly in the
development of retinal horizontal and amacrine cells, for example,
Table 2. Gene ontology of genes differentially expressed (a) in normal adult retina and (b) retinoblastoma
Cluster GO term Fold enrichment P-value
(a)
Annotation cluster 1 Enrichment score: 14.46
GOTERM_BP_FAT GO:0007601Bvisual perception 3.32 0.0000
GOTERM_BP_FAT GO:0050953Bsensory perception of light stimulus 3.32 0.0000
GOTERM_BP_FAT GO:0007600Bsensory perception 1.07 0.3013
Annotation cluster 2 Enrichment score: 8.82
GOTERM_BP_FAT GO:0008104Bprotein localisation 1.65 0.0000
GOTERM_BP_FAT GO:0045184Bestablishment of protein localisation 1.65 0.0000
GOTERM_BP_FAT GO:0015031Bprotein transport 1.64 0.0000
Annotation cluster 3 Enrichment score: 7.20
GOTERM_BP_FAT GO:0007602Bphototransduction 5.64 0.0000
GOTERM_BP_FAT GO:0009583Bdetection of light stimulus 5.01 0.0000
GOTERM_BP_FAT GO:0009582Bdetection of abiotic stimulus 3.29 0.0000
GOTERM_BP_FAT GO:0009581Bdetection of external stimulus 2.89 0.0000
GOTERM_BP_FAT GO:0051606Bdetection of stimulus 2.37 0.0000
Annotation cluster 4 Enrichment score: 6.15
GOTERM_BP_FAT GO:0046530Bphotoreceptor cell differentiation 5.58 0.0000
GOTERM_BP_FAT GO:0042461Bphotoreceptor cell development 5.43 0.0000
GOTERM_BP_FAT GO:0001754Beye photoreceptor cell differentiation 5.32 0.0000
GOTERM_BP_FAT GO:0042462Beye photoreceptor cell development 5.12 0.0000
Annotation cluster 5 Enrichment score: 5.25
GOTERM_MF_FAT GO:0043167Bion binding
GOTERM_MF_FAT GO:0046872Bmetal ion binding 1.17 0.0000
GOTERM_MF_FAT GO:0043169Bcation binding 1.16 0.0000
GOTERM_MF_FAT GO:0043169Bcation binding 1.16 0.0000
(b)
Annotation cluster 1 Enrichment score: 185.65
GOTERM_MF_FAT GO:0004984Bolfactory receptor activity 9.23 0.0000
GOTERM_BP_FAT GO:0007606Bsensory perception of chemical stimulus 7.95 0.0000
GOTERM_BP_FAT GO:0007608Bsensory perception of smell 8.35 0.0000
KEGG_PATHWAY hsa04740:Olfactory transduction 6.36 0.0000
GOTERM_BP_FAT GO:0007600Bsensory perception 4.96 0.0000
GOTERM_BP_FAT GO:0007186BG-protein-coupled receptor protein signalling pathway 4.09 0.0000
GOTERM_BP_FAT GO:0050890Bcognition 4.46 0.0000
GOTERM_BP_FAT GO:0050877Bneurological system process 3.50 0.0000
Annotation cluster 2 Enrichment score: 20.53
GOTERM_BP_FAT GO:0000279BM phase 3.44 0.0000
GOTERM_BP_FAT GO:0022403Bcell cycle phase 2.94 0.0000
GOTERM_BP_FAT GO:0022402Bcell cycle process 2.30 0.0000
GOTERM_BP_FAT GO:0007049Bcell cycle 2.07 0.0000
Annotation cluster 3 Enrichment score: 19.54
GOTERM_BP_FAT GO:0000280Bnuclear division 3.68 0.0000
GOTERM_BP_FAT GO:0007067Bmitosis 3.68 0.0000
GOTERM_BP_FAT GO:0000087BM phase of mitotic cell cycle 3.62 0.0000
GOTERM_BP_FAT GO:0048285Borganelle fission 3.54 0.0000
GOTERM_BP_FAT GO:0000278Bmitotic cell cycle 2.64 0.0000
Annotation cluster 4 Enrichment score: 7.86
GOTERM_BP_FAT GO:0051321Bmeiotic cell cycle 3.46 0.0000
GOTERM_BP_FAT GO:0051327BM phase of meiotic cell cycle 3.41 0.0000
GOTERM_BP_FAT GO:0007126Bmeiosis 3.41 0.0000
Annotation cluster 5 Enrichment score: 5.79
GOTERM_BP_FAT GO:0065004Bprotein-DNA complex assembly 3.67 0.0000
GOTERM_BP_FAT GO:0031497Bchromatin assembly 3.56 0.0000
GOTERM_BP_FAT GO:0006334Bnucleosome assembly 3.41 0.0000
GOTERM_BP_FAT GO:0034728Bnucleosome organisation 3.20 0.0000
GOTERM_BP_FAT GO:0006333Bchromatin assembly or disassembly 2.63 0.0000
GOTERM_BP_FAT GO:0006325Bchromatin organisation 1.07 0.4285
Abbreviation: GO¼gene ontology. Genes with at least two-fold (qp0.05) differential expression in normal adult retina vs retinoblastoma were analysed using DAVID
(http://david.abcc.ncifcrf.gov). The top five most highly enriched clusters of GO terms are presented. The group enrichment score used to rank biological significance is the geometric
mean (in  log scale) of member’s P-values in a corresponding annotation cluster. GOTERM_BP: Biological Process. GOTERM_MF: Molecular function. G0_FAT: includes a subset of the Gene
Ontology term set created in order to filter the broadest terms so that they do not overshadow the more specific terms.
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Table 3. Gene ontology of genes differentially expressed in (a) group 1 and (b) group 2, both relative to group 3
Cluster GO Term Fold enrichment P-value
(a)
Annotation cluster 1 Enrichment score: 34.87
GOTERM_BP_FAT GO:0000279BM phase 8.99 0.0000
GOTERM_BP_FAT GO:0022403Bcell cycle phase 7.49 0.0000
GOTERM_BP_FAT GO:0007067Bmitosis 10.46 0.0000
GOTERM_BP_FAT GO:0000280Bnuclear division 10.46 0.0000
GOTERM_BP_FAT GO:0000087BM phase of mitotic cell cycle 10.28 0.0000
GOTERM_BP_FAT GO:0048285Borganelle fission 10.05 0.0000
GOTERM_BP_FAT GO:0022402Bcell cycle process 5.82 0.0000
GOTERM_BP_FAT GO:0000278Bmitotic cell cycle 7.11 0.0000
Annotation cluster 2 Enrichment score: 29.41
GOTERM_MF_FAT GO:0004984Bolfactory receptor activity 9.12 0.0000
GOTERM_BP_FAT GO:0007608Bsensory perception of smell 7.74 0.0000
GOTERM_BP_FAT GO:0007606Bsensory perception of chemical stimulus 7.17 0.0000
KEGG_PATHWAY hsa04740:Olfactory transduction 5.66 0.0000
GOTERM_BP_FAT GO:0007600Bsensory perception 4.29 0.0000
GOTERM_BP_FAT GO:0050890Bcognition 3.82 0.0000
GOTERM_BP_FAT GO:0007186BG-protein-coupled receptor protein signalling pathway 3.39 0.0000
GOTERM_BP_FAT GO:0050877Bneurological system process 2.99 0.0000
GOTERM_BP_FAT GO:0007166Bcell surface receptor linked signal transduction 2.15 0.0000
Annotation cluster 3 Enrichment score: 10.49
GOTERM_BP_FAT GO:0065004Bprotein-DNA complex assembly 11.36 0.0000
GOTERM_BP_FAT GO:0031497Bchromatin assembly 10.80 0.0000
GOTERM_BP_FAT GO:0006334Bnucleosome assembly 10.62 0.0000
GOTERM_BP_FAT GO:0034728Bnucleosome organisation 9.60 0.0000
GOTERM_BP_FAT GO:0006333Bchromatin assembly or disassembly 7.40 0.0000
GOTERM_BP_FAT GO:0034621Bcellular macromolecular complex subunit organisation 3.55 0.0000
GOTERM_BP_FAT GO:0034622Bcellular macromolecular complex assembly 3.69 0.0000
GOTERM_BP_FAT GO:0006325Bchromatin organisation 2.73 0.0001
Annotation cluster 4 Enrichment score: 8.65
GOTERM_BP_FAT GO:0051327BM phase of meiotic cell cycle 7.67 0.0000
GOTERM_BP_FAT GO:0007126Bmeiosis 7.67 0.0000
GOTERM_BP_FAT GO:0051321Bmeiotic cell cycle 7.52 0.0000
Annotation CLUSTER 5 Enrichment score: 8.27
GOTERM_BP_FAT GO:0006974Bresponse to DNA damage stimulus 3.90 0.0000
GOTERM_BP_FAT GO:0006281BDNA repair 4.47 0.0000
GOTERM_BP_FAT GO:0033554Bcellular response to stress 2.66 0.0000
(b)
Annotation cluster 1 Enrichment score: 66.78
GOTERM_BP_FAT GO:0022403Bcell cycle phase 10.48 0.0000
GOTERM_BP_FAT GO:0000279BM phase 11.91 0.0000
GOTERM_BP_FAT GO:0022402Bcell cycle process 8.34 0.0000
Annotation cluster 2 Enrichment score: 53.36
GOTERM_BP_FAT GO:0000278Bmitotic cell cycle 9.83 0.0000
GOTERM_BP_FAT GO:0007067Bmitosis 13.57 0.0000
GOTERM_BP_FAT GO:0000280Bnuclear division 13.57 0.0000
GOTERM_BP_FAT GO:0000087BM phase of mitotic cell cycle 13.33 0.0000
GOTERM_BP_FAT GO:0048285Borganelle fission 13.04 0.0000
Annotation cluster 3 Enrichment score: 21.83
GOTERM_BP_FAT GO:0006281BDNA repair 7.23 0.0000
GOTERM_BP_FAT GO:0006974Bresponse to DNA damage stimulus 6.13 0.0000
GOTERM_BP_FAT GO:0033554Bcellular response to stress 4.29 0.0000
Annotation cluster 4 Enrichment score: 14.86
GOTERM_BP_FAT GO:0007126Bmeiosis 10.47 0.0000
GOTERM_BP_FAT GO:0051327BM phase of meiotic cell cycle 10.47 0.0000
GOTERM_BP_FAT GO:0051321Bmeiotic cell cycle 10.26 0.0000
Annotation cluster 5 Enrichment score: 13.93
GOTERM_BP_FAT GO:0065004Bprotein-DNA complex assembly 12.82 0.0000
GOTERM_BP_FAT GO:0031497Bchromatin assembly 12.33 0.0000
GOTERM_BP_FAT GO:0034728Bnucleosome organisation 11.04 0.0000
GOTERM_BP_FAT GO:0006334Bnucleosome assembly 11.66 0.0000
GOTERM_BP_FAT GO:0006333Bchromatin assembly or disassembly 8.45 0.0000
GOTERM_BP_FAT GO:0034622Bcellular macromolecular complex assembly 4.40 0.0000
GOTERM_BP_FAT GO:0006325Bchromatin organisation 3.21 0.0000
Abbreviation: GO¼gene ontology. Genes with at least two-fold (qp0.05) differential expression in group 1 or group 2 vs group 3 were analysed using DAVID (http://david.abcc.ncifcrf.gov).
The top five most highly enriched clusters of GO terms are presented.
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FOXN4, PTFIA and MITF (Fujitani et al, 2006). These results
suggest that group 1 retinoblastomas have the potential for at least
the early stages of differentiation of more than one retinal cell type.
To further validate these results, quantitative RT-PCR was
carried out for selected genes characteristic of each of the three
groups. In the case of all genes tested (FOXN4, ARR3, RXRG, RHO,
NR2E3 and PAX6), expression patterns were in agreement with the
array results (Supplementary Figure S1).
Histopathology and cytogenetics of retinoblastoma sub-types.
We next examined whether the genetic classification of retino-
blastomas into different groups, with differing levels of cone
photoreceptor differentiation, was related to histopathological or
cytogenetic characteristics. A detailed histopathological review of
all retinoblastomas (carried out by a reviewer without knowledge of
the genetic data) showed relatively good agreement between
genetic and histological definitions of photoreceptor differentiation
(Table 1). Four out of six (66.7%) group 2 retinoblastomas were
classified as well differentiated on the basis of histological features
(the extent of photoreceptor-like Flexner-Wintersteiner rosettes),
compared with only 3 out of 13 (23.1%) group 1 retinoblastomas.
However, these figures may under-estimate the extent of correla-
tion between genetic and histopathological data, as tissue used for
genetic analysis was representative of only a small part of the
tumour. It is also of interest that group 1 retinoblastomas showed
an increased frequency of both post-laminar optic nerve invasion
(PLONI, 6 out of 13, 46.1%) and deep choroid invasion (DCI, 8 out
of 13, 61.5%) compared with group 2 (1 out of 6, 16.7% and 2 out
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Figure 3. Hierarchical clustering of retina and retinoblastoma based on 80 genes associated with retinal development and function.
Abbreviations: aRET, adult retina; fRET, fetal retina. *Cone-enriched genes; **Rod-enriched genes.
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of 8, 25.0% for PLONI and DCI respectively), although these
differences did not reach statistical significance (Table 1). Patients
with these features are considered to be at higher risk of
extra-ocular tumour spread (Shields et al, 2006). Surprisingly, the
frequency of apoptotic cells was also significantly higher in group 1
retinoblastomas (P¼ 0.004).
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Figure 4. Array-CGH of retinoblastomas. The chromosomes with the most frequent copy number alterations were chromosomes 1, 6 and 16.
These alterations were restricted to group 1 retinoblastomas.
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The occurrence of cytogenetic alterations most frequently
reported to be associated with adverse clinical features was also
investigated, that is, gain of chromosomes 1q and 6p and loss of
chromosome 16q. Array-CGH of 19 samples for which material
was available showed that these alterations tended to occur
together and were significantly more frequent in group 1
retinoblastomas (P¼ 0.003 for any alteration; P¼ 0.029 for 6p
gain) (Table 1, Figure 4). Overall, these results lend further weight
to the classification of retinoblastoma into two distinct groups with
differing genetic and clinical characteristics.
Table 4. Gene ontology of genes differentially expressed in (a) group 2 and (b) group 3 relative to group 1
Cluster GO term Fold enrichment P-value
(a)
Annotation cluster 1 Enrichment score: 9.60
GOTERM_BP_FAT GO:0050953Bsensory perception of light stimulus 8.45 0.0000
GOTERM_BP_FAT GO:0007601Bvisual perception 8.45 0.0000
GOTERM_BP_FAT GO:0050890Bcognition 2.28 0.0000
GOTERM_BP_FAT GO:0007600Bsensory perception 2.33 0.0000
GOTERM_BP_FAT GO:0050877Bneurological system process 1.98 0.0001
Annotation cluster 2 Enrichment score: 5.52
GOTERM_BP_FAT GO:0007602Bphototransduction 19.07 0.0000
GOTERM_BP_FAT GO:0009583Bdetection of light stimulus 16.13 0.0000
GOTERM_BP_FAT GO:0009582Bdetection of abiotic stimulus 9.68 0.0000
GOTERM_BP_FAT GO:0009581Bdetection of external stimulus 8.50 0.0000
GOTERM_BP_FAT GO:0009416Bresponse to light stimulus 5.47 0.0000
GOTERM_BP_FAT GO:0051606Bdetection of stimulus 5.33 0.0001
GOTERM_BP_FAT GO:0009314Bresponse to radiation 3.78 0.0003
GOTERM_BP_FAT GO:0009628Bresponse to abiotic stimulus 2.74 0.0008
Annotation cluster 3 Enrichment score: 4.19
GOTERM_BP_FAT GO:0042462Beye photoreceptor cell development 18.88 0.0000
GOTERM_BP_FAT GO:0001754Beye photoreceptor cell differentiation 17.98 0.0000
GOTERM_BP_FAT GO:0042461Bphotoreceptor cell development 15.73 0.0000
GOTERM_BP_FAT GO:0046530Bphotoreceptor cell differentiation 15.10 0.0000
GOTERM_BP_FAT GO:0048592Beye morphogenesis 5.47 0.0047
Annotation cluster 4 Enrichment score: 3.06
GOTERM_BP_FAT GO:0048858Bcell projection morphogenesis 3.60 0.0001
GOTERM_BP_FAT GO:0032990Bcell part morphogenesis 3.44 0.0002
GOTERM_BP_FAT GO:0032989Bcellular component morphogenesis 2.38 0.0043
GOTERM_BP_FAT GO:0000902Bcell morphogenesis 2.47 0.0044
Annotation cluster 5 Enrichment score: 1.96
GOTERM_BP_FAT GO:0010324Bmembrane invagination 2.86 0.0084
GOTERM_BP_FAT GO:0006897Bendocytosis 2.86 0.0084
GOTERM_BP_FAT GO:0016044Bmembrane organisation 2.15 0.0183
(b)
Annotation cluster 1 Enrichment score: 20.08
GOTERM_BP_FAT GO:0050953Bsensory perception of light stimulus 5.17 0.0000
GOTERM_BP_FAT GO:0007601Bvisual perception 5.17 0.0000
GOTERM_BP_FAT GO:0007600Bsensory perception 1.59 0.0001
Annotation cluster 2 Enrichment score: 10.44
GOTERM_BP_FAT GO:0007602Bphototransduction 10.40 0.0000
GOTERM_BP_FAT GO:0009583Bdetection of light stimulus 8.80 0.0000
GOTERM_BP_FAT GO:0009582Bdetection of abiotic stimulus 5.81 0.0000
GOTERM_BP_FAT GO:0009581Bdetection of external stimulus 5.10 0.0000
GOTERM_BP_FAT GO:0051606Bdetection of stimulus 3.78 0.0000
GOTERM_BP_FAT GO:0009416Bresponse to light stimulus 3.36 0.0000
Annotation cluster 3 Enrichment score: 6.40
GOTERM_BP_FAT GO:0031644Bregulation of neurological system process 3.14 0.0000
GOTERM_BP_FAT GO:0051969Bregulation of transmission of nerve impulse 3.15 0.0000
GOTERM_BP_FAT GO:0050804Bregulation of synaptic transmission 3.16 0.0000
Annotation cluster 4 Enrichment score: 6.03
GOTERM_BP_FAT GO:0048858Bcell projection morphogenesis 2.73 0.0000
GOTERM_BP_FAT GO:0032990Bcell part morphogenesis 2.62 0.0000
GOTERM_BP_FAT GO:0030030Bcell projection organisation 2.24 0.0000
GOTERM_BP_FAT GO:0048667Bcell morphogenesis involved in neuron differentiation 2.63 0.0000
GOTERM_BP_FAT GO:0031175Bneuron projection development 2.41 0.0000
GOTERM_BP_FAT GO:0048812Bneuron projection morphogenesis 2.50 0.0000
GOTERM_BP_FAT GO:0007409Baxonogenesis 2.40 0.0001
Annotation cluster 5 Enrichment score: 4.88
GOTERM_BP_FAT GO:0008104Bprotein localisation 1.67 0.0000
GOTERM_BP_FAT GO:0045184Bestablishment of protein localisation 1.65 0.0000
GOTERM_BP_FAT GO:0015031Bprotein transport 1.62 0.0000
Abbreviation: GO¼gene ontology. Genes with at least two-fold (qp0.05) differential expression in group 2 or group 3 vs group 1 were analysed using DAVID (http://david.abcc.ncifcrf.gov).
The top five most highly enriched clusters of GO terms are presented.
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Table 5. Differentially expressed genes on chromosomes 1q, 6p and 16q
Gene symbol Gene name Cyto band Fold change q (%)
CKS1B CDC28 protein kinase regulatory subunit 1B 1q21.2 2.1 1.3
HDGF Hepatoma-derived growth factor 1q23.1 1.7 0.0
VANGL2 Vang-like 2 (van gogh, Drosophila) 1q23.2 1.5 1.3
NUF2 NUF2, NDC80 kinetochore complex component 1q23.3 2.7 0.8
CENPL Centromere protein L 1q25.1 1.6 0.9
CACYBP Calcyclin-binding protein 1q25.1 1.6 0.7
ASPM Asp (abnormal spindle) homolog, 1q31 2.6 2.0
KIF14 Kinesin family member 14 1q32.1 2.3 1.0
NR5A2 Nuclear receptor subfamily 5, group A, member 2 1q32.1 1.8 0.5
YOD1 YOD1 OTU deubiquinating enzyme 1 1q32.2 1.5 0.0
NEK2 NIMA (never in mitosis gene a)-related kinase 2 1q32.3 2.0 4.1
CENPF Centromere protein F (mitosin) 1q41 2.4 2.7
PRIM2 Primase, DNA, polypeptide 2 6p11.2 1.7 0.4
MCM3 Minichromosome maintenance complex component 3 6p12 1.7 0.3
BMP5 Bone morphogenetic protein 5 6p12.1 1.7 0.0
TFAP2D Transcription factor AP-2 delta 6p12.1 1.6 0.2
OPN5 Opsin 5 6p12.3 2.0 0.0
RUNX2 Runt-related transcription factor 2 6p21 1.7 0.0
UHRF1BP1 UHRF1-binding protein 1 6p21 1.5 0.0
CDC5L CDC5 cell division cycle 5-like 6p21 1.5 0.8
STK38 Serine/threonine kinase 38 6p21 1.9 0.1
USP49 Ubiquitin-specific peptidase 49 6p21 1.8 0.1
POLH Polymerase (DNA directed), eta 6p21.1 1.7 0.1
FOXP4 Forkhead box P4 6p21.1 1.5 0.1
PIM1 Pim-1 oncogene 6p21.2 1.7 0.0
TEAD3 TEA domain family member 3 6p21.2 1.6 0.0
DAXX Death-domain associated protein 6p21.3 1.6 0.0
KIFC1 Kinesin family member C1 6p21.3 2.2 0.0
EHMT2 euchromatic histone-lysine N-methyltransferase 2 6p21.31 1.5 0.1
FANCE Fanconi anaemia, complementation group E 6p21.31 1.8 0.0
E2F3 E2F transcription factor 3 6p22 1.5 0.2
JARID2 Jumonji, AT rich interactive domain 2 6p22.3 1.5 0.2
DEK DEK oncogene 6p22.3 1.5 0.4
CDKAL1 CDK5 regulatory subunit associated protein 1-like 1 6p22.3 1.7 0.1
NUP153 Nucleoporin 153 kDa 6p22.3 1.6 0.1
SOX4 SRY-box 4 6p22.3 1.6 0.1
RNF182 Ring finger protein 182 6p23 1.5 0.2
PRPF4B PRP4 pre-mRNA processing factor 4 homolog B 6p25.2 1.5 0.3
RNF8 RING finger protein 8 6p31.3 1.6 0.0
N4BP1 NEDD4-binding protein 1 16q12.1 2.0 1.2
CHD9 Chromodomain helicase DNA-binding protein 9 16q12.2 3.1 0.0
RBL2 retinoblastoma-like 2 (p130) 16q12.2 2.4 1.2
RPGRIP1L RPGRIP1-like 16q12.2 2.3 2.4
RSPRY1 Ring finger and SPRY domain containing 1 16q13 2.2 0.8
BBS2 Bardet-Biedl syndrome 2 16q21 3.0 0.0
CNOT1 CCR4-NOT transcription complex, subunit 1 16q21 2.1 0.0
NAE1 NEDD8 activating enzyme E1 16q22 2.0 4.2
PRMT7 Protein arginine methyltransferase 7 16q22.1 1.6 1.2
SF3B3 Splicing factor 3b, subunit 3, 16q22.1 1.9 1.2
TERF2 Telomeric repeat-binding factor 2 16q22.1 1.9 4.1
WWP2 WW domain containing E3 ubiquitin protein ligase 2 16q22.1 1.7 2.4
TXNL4B Thioredoxin-like 4B 16q22.2 1.9 4.1
CDK10 Cyclin-dependent kinase 10 16q24 1.5 0.8
USP10 Ubiquitin-specific peptidase 10 16q24.1 2.5 4.1
FBXO31 F-box protein 31 16q24.2 1.6 1.0
TCF25 Transcription factor 25 (basic helix-loop-helix)/NULP1 16q24.3 2.5 1.1
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Gene expression changes associated with recurrent chromosome
alterations. We next asked whether the altered pattern of
differentiation in group 1 retinoblastomas might be related to the
expression of genes on chromosomes 1q, 6p and 16q. SAM
analyses identified a total of 555 genes mapping to these
chromosomal regions, which showed significantly altered expres-
sion (fold changeX1.5; FDR qp0.05) in retinoblastomas with the
relevant chromosomal alteration (Supplementary Table S5). A
subset of 56 protein-coding genes had functions which potentially
could contribute to retinoblastoma tumorigenesis (based on
involvement in other tumour types or in cell regulatory processes)
or which are relevant to retinal/photoreceptor development and
function (Table 5).
Chromosome 1q genes identified in retinoblastomas with 1q gain
included several with functions in mitosis, particularly centrosome
duplication, chromosome segregation and the mitotic spindle
checkpoint (ASPM, CENPF, KIF14, NUF2, NEK2). Additional
chromosome 1q genes identified have functions in promoting cell
cycle progression (CKS1B) and transcriptional regulation during
development (NR5A2).
Chromosome 6p genes that showed increased expression in
association with 6p gain again emphasised the same functional
categories highlighted by 1q genes, for example, mitosis (KIFC1,
NUP153), cell cycle progression (E2F3, UHRF1BP1) and develop-
mental transcriptional regulation (FOXP4, SOX4, TEAD3). TEAD3
is a downstream target of the Hippo pathway, and it is of interest
that combined inactivation of RB and Hippo pathway kinases has
been shown to result in dedifferentiation in the Drosophila retina
(Nicolay et al, 2010). Chromosome 6p genes also included several
with roles in the epigenetic regulation of gene expression,
particularly through modification of chromatin (DAXX, DEK,
EHMT2, JARID2, RUNX2, PRPF4B).
Genes which were downregulated in association with 16q loss
included RBL2 (p130), which has an essential role in maintaining
permanent cell cycle arrest and senescence following events
initiated by RB1 (Helmbold et al, 2011). It is of interest that
RBL2 expression was reduced not only in retinoblastomas with 16q
loss (N¼ 4), but also showed a 2.2-fold decrease overall in group 1
retinoblastomas relative to group 2, which may reflect epigenetic
regulation (De Falco and Giordano, 2006). Other 16q genes
identified included USP10, which is upregulated in response to
DNA damage and which stabilises p53, also FBXO31 and NAE1,
which function in ubiquitin pathways to regulate cell cycle
progression, cell growth and survival, and CHD9 and PRMT7,
which have roles in chromatin remodelling, with the latter also
implicated in the DNA damage response (Karkhanis et al, 2012). A
further consequence of chromosome 16q loss was the decreased
expression of BBS2 and RPGRIP1L, which are required for retinal
photoreceptor function.
Geneset enrichment analysis analysis of regulatory pathways in
group 1 and group 2 retinoblastomas. Geneset enrichment
analysis was used to obtain further information about the
regulatory pathways responsible for the differing characteristics
of group 1 and 2 retinoblastomas. Genesets enriched in group 1
retinoblastomas included several related to G-protein-coupled
receptor-mediated signalling (Supplementary Table S6). There was
a strong emphasis on neurotransmitter signalling, particularly
involving class A1 (RHO-like) GPCRs, which include the amine
ligand-binding receptors (e.g., serotonin, adrenergic and
cholinergic receptors) and peptide ligand-binding receptors
(hypocretin/orexin, NPY, melanocortin and tachykinin receptors)
(Supplementary Figure S2). These results are of interest as although
glutamine is the major neurotransmitter within the retina,
particularly for photoreceptor, bipolar and ganglion cells, addi-
tional neurotransmitters/receptors are a feature of other cell types.
Serotonin and NPY, for example, are associated with subsets of
amacrine cells (Bagnoli et al, 2003; Ghai et al, 2009), tachykinins
with amacrine and ganglion cells, and orexins with horizontal,
bipolar, amacrine and ganglion cells (Kolb et al, 1995; Savaskan
et al, 2004). This genome-wide analysis of gene expression patterns
is consistent with the idea that group 1 retinoblastomas show
characteristics of multiple retinal cell types.
In the case of group 2 retinoblastomas, many significantly
enriched genesets were relevant to photoreceptor function,
particularly mitochondrial function/energy metabolism as well as
transcription and RNA splicing (Supplementary Table S6,
Supplementary Figure S3). Photoreceptors, especially cones, are
among the most metabolically active cells in the body (Eckmiller
2004; Reidel et al, 2011), and normal retinal/photoreceptor
functions maintained in group 2 retinoblastomas may promote
tumour growth.
DISCUSSION
The aetiology of retinoblastoma and its relationship to retinal
histogenesis have been intensively studied. However, as yet there is
still relatively little consensus on the cell-of-origin or the molecular
mechanisms involved. Our results suggest that retinoblastomas, like
most other tumour types, are not a homogeneous group but may be
classified into at least two different sub-types based on molecular
and histopathological characteristics. Furthermore we suggest that
these sub-types may have differing aetiology and origin.
Classification of retinoblastomas. Our results, based on gene
expression profiling, are consistent with the existence of two sub-
types of retinoblastoma, group 1 retinoblastomas that show
features of multiple retinal cell types, and group 2 retinoblastomas
that show a distinctive cone photoreceptor expression profile. This
sub-division is further supported by the finding that recurrent
chromosomal alterations typical of retinoblastoma (1q loss, 6p gain
and 16q loss) were restricted to group 1 tumours, and in addition
suggest that the genetic mechanisms driving tumorigenesis in each
group may also be distinct. It was also noted that adverse
histopathological features (PLONI and deep choroid invasion)
were more frequent in group 1 retinoblastomas.
Our classification of retinoblastoma is in contrast to two
previous reports, which emphasised the overall similarity between
retinoblastomas, but nevertheless also provides support for both of
these studies (Xu et al, 2009; McEvoy et al, 2011). Xu et al (2009)
proposed a cone precursor origin for retinoblastoma (similar to our
group 2 tumours), following immunohistochemical detection of
cone-specific markers RXRG, THRB and cone arrestin in all 40
retinoblastomas examined. Consistent with this finding, both our
group 1 and 2 retinoblastomas expressed genes encoding these
proteins, albeit at higher levels in group 2. Similarly, the failure to
detect several developmental markers of other retinal cell types
(PROX1, CHX10/VSX2, PAX6) in retinoblastoma cells in the study
of Xu et al (2009) is also consistent with our observation that these
genes were significantly downregulated in both group 1 and 2
retinoblastomas relative to normal adult and normal fetal retina
(Figure 3). We conclude, therefore, that the results of Xu et al
(2009) do not exclude the possibility that some retinoblastomas
also have characteristics of non-cone retinal cell types.
McEvoy et al (2011) concluded from gene expression analyses
that retinoblastoma tumour cells express genes associated with
multiple retinal cell types. This is similar to our findings for group
1 retinoblastomas. However, further examination of the data of
McEvoy et al (2009; GEO:GSE29683) on 52 human retinoblasto-
mas suggests that there is a significant range of expression values
for individual retinal cell type-specific genes in this large complex
data set (Supplementary Figure S4). These results are not
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inconsistent with the idea that some retinoblastomas have a
predominantly cone-like expression profile.
The retinoblastoma cell-of-origin. The identification of different
sub-types of retinoblastoma raises the question as to whether these
represent divergent evolution from a common tumour progenitor
cell or alternatively if there is a different cell-of-origin in each case.
It is important to consider this question in the context of normal
retinal development. Retinal progenitor cells progress through a
series of competence states during development, giving rise to
retinal cell type-specific precursors in a temporally restricted
manner, a process which may be regulated at least in part by the
sequential expression of retinal transcription factors (Ohsawa and
Kageyama, 2008; Agathocleous and Harris, 2009). However, there
is considerable overlap in the generation of different cell types and
individual progenitor cells from the same developmental time
point not only show extensive heterogeneity of gene expression but
may also express genes encoding multiple retinal transcription
factors within a single cell (Trimarchi et al, 2008). Consistent with
these observations, recent evidence suggests that RPCs show a
surprising level of stochasticity in cell fate choice, and the observed
variability in the number and type of cells resulting from clonal
expansion of individual RPCs (a RPC may divide to produce two
daughter RPCs (P/P), a RPC and a differentiating cell (P/D) or two
differentiating cells (not necessarily identical) (D/D)) fits well with
a model in which cells divide or differentiate with fixed
probabilities related to the ratios of different cell types in the
normal retina (Gomes et al, 2011; He et al, 2012).
Taking this information into consideration, we propose a model
for group 1 retinoblastomas in which these tumours arise from a
RPC in which the balance between P/P, P/D and D/D divisions is
disrupted to favour continued proliferation, but with individual
tumour cells showing stochastic regulation of lineage progression and
variable patterns of gene expression. The higher level of apoptosis
observed in group 1 retinoblastomas, compared with group 2, may
reflect a proportion of tumour cells that undergo terminal D/D
divisions. This model is consistent with published expression data on
single retinoblastoma cells (McEvoy et al, 2011). Examination of this
data indicates that single cells obtained following repeated ( 3)
passage of a human retinoblastoma in mice do not show selection for
a single retinal lineage but instead display a high level of inter-cell
variability in the pattern of transcription factor expression
(Supplementary Figure S5). These results support the idea that
stochastic regulation of cell fate is an inherent characteristic of these
retinoblastomas, as well as of normal retina.
Group 2 retinoblastomas in contrast are characterised by a
stable pattern of cone photoreceptor gene expression, including not
only genes encoding cone-enriched transcription factors but also
multiple genes required for photoreceptor structure and function
(Supplementary Table S2). These retinoblastomas might arise in a
RPC in which the stochastic regulation of cell fate is strongly biased
towards a cone cell lineage. Alternatively, they may originate in an
RXRG-expressing precursor cell, primed for cone differentiation,
which has failed to undergo cell cycle exit. Continued proliferation
may be a consequence of the combined effects of pRB loss and also
upregulation of genes responsible for cell cycle progression, for
example, cyclin E2 and the mitotic cyclin-dependent kinase, CDK1,
which showed 1.9- to 2.1-fold increased expression in group 2
relative to group 1 retinoblastoma and even larger increases relative
to fetal and adult retina (results not shown).
The molecular aetiology of group 1 retinoblastomas. The
restricted occurrence of chromosome 1q and 6p gain and 16q loss
in group 1 retinoblastomas suggests that genes on these chromo-
somes are relevant to the aetiology of this tumour group. In
agreement with previous reports, this study identified several
functionally related genes with roles in spindle microtubule
organisation and kinetochore/centrosome-mediated mitotic
functions, for example, KIF14, CENPF, ASPM, NEK2 and NUF2
on chromosome 1 and KIFC1 on chromosome 6p (Grassmann
et al, 2005; Gratias et al, 2005; Orlic et al, 2006; Bowles et al, 2007;
Ganguly and Shields, 2010). These genes have particular relevance
for group 1 retinoblastomas, as orientation of the mitotic spindle
has been shown to influence the distribution of cell-fate
determinants to one or both daughter cells, thereby producing
symmetric (P/P, D/D) or asymmetric cell divisions (P/D or D/D
with different cell types). In the retina, RPCs with horizontally
oriented spindles (relative to the retinal pigment epithelium)
generate identical daughter cells, while vertically oriented spindles
tend to generate two different daughters, and it has been suggested
that even slight changes in spindle orientation may influence the
outcome of cell division (Cayouette et al, 2006). Proteins such as
ASPM have been shown to be critical for the maintenance of
symmetric divisions in the developing CNS (Nigg and Stearns,
2011), and it is tempting to speculate that increased expression of
ASPM might have a similar function in retinoblastoma, resulting in
increased production of RPCs.
Genes on chromosomes 1q, 6p and 16q may also contribute to
tumorigenesis through more direct effects on cell cycle regulation. An
important consequence of loss of pRB function is aberrant regulation
of the G1–S transition and these genes may further potentiate this
effect through over-riding downstream cell cycle checkpoints. Of
particular interest is the upregulation of the chromosome 1q gene
CKS1B, which has an essential role in the SKP2-mediated
ubiquitination of a range of cell cycle inhibitory proteins including
p27/CDKN1B and also p130/RBL2 (Tedesco et al, 2002; Krishnan
et al, 2010; Liberal et al, 2011). CKS1B maps to 1q21, a common
region of gain in cancer, and its amplification/overexpression has
been reported in many tumours (Wang et al, 2009; Chen et al, 2010;
Krishnan et al, 2010). Also of interest is the downregulation of the
16q gene USP10, which de-ubiquinates p53 and is an essential
regulator of its stability (Yuan et al, 2010). It has been suggested that
loss of USP10 provides an alternative mechanism to antagonise p53
function in tumours such as renal cell carcinoma, which (like
retinoblastoma) do not have a high frequency of p53 mutations
(Yuan et al, 2010). USP10 was also identified by Gratias et al (2007)
in a search for genes mapping to 16q24, which were differentially
expressed in retinoblastomas with 16q LOH.
Although investigation of the molecular consequences of
chromosome alterations in group 1 retinoblastomas provides clues
about pathways which are aberrantly regulated in tumorigenesis, it
is also important to identify the primary mitogenic signal(s).
Potential candidates include growth factors, neurotrophins and
neurotransmitters, all of which have been implicated in the
regulation of cell proliferation in the developing retina (Martins
and Pearson, 2008). Our GSEA analysis points to a role for
neurotransmitter signalling, especially through amine and peptide
ligand-binding receptors. This is a significant result as it provides
further support for the novel finding of McEvoy et al (2011) that
among paediatric solid tumour cell lines, the retinoblastoma cell
lines Y79 and WERI1 are uniquely sensitive to broad-acting
monoamine receptor inhibitors, and that blockade specifically of
amine receptors (but not other major neurotransmitter signalling
pathways) reduced retinoblastoma growth and survival. Inhibition
of neurotransmitter signalling may therefore have important
therapeutic potential in retinoblastoma.
The molecular aetiology of group 2 retinoblastomas. Group 2
retinoblastomas were observed to have a gene expression signature
strongly indicative of differentiation along a cone photoreceptor
lineage. This is consistent with the observation that human
differentiated cone photoreceptors (but not early cone precursors)
stain strongly for pRB, suggesting that pRB does not mediate the
initial proliferative arrest in these cells (Lee et al, 2006), but may
be important for maintaining cell cycle exit and differentiation.
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A consequence of loss of RB function may be to permit cell cycle
re-entry of cells, which otherwise are competent to form mature
photoreceptors and have all of the components required for the
visual cycle.
Our results suggest that there are two main features of cone
photoreceptors which have relevance for tumorigenesis in group 2
retinoblastomas. The first is the extremely high metabolism of this
cell type – photoreceptors are among the most metabolically active
cells in the body (Reidel et al, 2011). Of particular note in group 2
retinoblastomas was the upregulation of multiple components of
the TCA and oxidative phosphorylation (OXPHOS) pathways.
Although tumour cells are frequently reported to use aerobic
glycolysis in preference to OXPHOS (Warburg effect), there is
increasing evidence that OXPHOS and glycolysis cooperate to
sustain energy needs in tumorigenesis, with dynamic regulation
reflecting the tumour microenvironment (Jose et al, 2011). Our
results, and those of Chen et al (2007), suggest that in environments
such as the retina and the brain where energy demand is high,
tumour cells use enhanced mitochondrial respiratory pathways for
energy production. The very high metabolic activity of retinal
photoreceptor cells is also paralleled by elevated transcriptional and
translational activity, and it is of interest that mutations of several
pre-mRNA processing genes (e.g., PRPF3, PRPF31, PRPC8) are
associated with retinal disease phenotypes (Cao et al, 2011;
Tanackovic et al, 2011). Elevated mRNA processing, observed in
group 2 retinoblastomas, may impact on tumorigenesis both
through an overall promotion of cell growth and division, but
potentially also through a generalised loss of splicing fidelity which
is a hallmark of cancer (Ghigna et al, 2008). Overall these results
suggest that cellular and metabolic adaptations for efficient
photoreceptor function in the normal retina may also contribute
to a growth advantage for tumour cells in this microenvironment,
and that this may account for the particular sensitivity of cone
photoreceptor cells to oncogenic transformation.
CONCLUSIONS
In summary, the results of this study suggest that the molecular
aetiology of retinoblastoma reflects aberrant regulation of develop-
mental processes required for the highly ordered production of the
different retinal cell types from a single progenitor cell. Although
we cannot exclude the possibility that retinoblastomas represent a
broad spectrum of developmental phenotypes, nevertheless our
results suggest that most tumours arise from either a RPC or a
committed cone precursor. Our findings are important for the
development of novel targeted therapeutics for retinoblastoma and,
in addition, strongly suggest that the clinical significance of
retinoblastoma molecular heterogeneity merits further
investgation.
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